Cargando…

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer

Androgens and the androgen receptor (AR) are essential for growth and differentiation of the normal prostate gland as well as proliferation and survival of prostate cancer (PCa). Increasing evidence suggests that reactivation of the AR plays a pivotal role in disease progression to castration-resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yu, Tindall, Donald J., Huang, Haojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062954/ https://www.ncbi.nlm.nih.gov/pubmed/24948874 http://dx.doi.org/10.7150/ijbs.8389

Ejemplares similares

Posttranslational Modification of the Androgen Receptor in Prostate Cancer
por: van der Steen, Travis, et al.
Publicado: (2013)

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Cooperativity and Equilibrium with FOXA1 Define the Androgen Receptor Transcriptional Program
por: Jin, Hong-Jian, et al.
Publicado: (2014)

FOXA1 in prostate cancer
por: Dong, Hui-Yu, et al.
Publicado: (2022)

Androgen receptor signaling in prostate cancer development and progression
por: Lonergan, Peter E, et al.
Publicado: (2011)

FOXA1 inhibits prostate cancer neuroendocrine differentiation
por: Kim, Jung, et al.
Publicado: (2017)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
por: He, Yundong, et al.
Publicado: (2018)

Epithelial Transcription Factor FOXA1 Regulates Prostate Cancer Immune Response
por: Brea, Lourdes T, et al.
Publicado: (2021)

FOXA1 regulates alternative splicing in prostate cancer
por: Del Giudice, Marco, et al.
Publicado: (2022)

Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers
por: Park, Seho, et al.
Publicado: (2017)

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies
por: Hwang, Justin H, et al.
Publicado: (2022)

A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1
por: Biernacka, K.M., et al.
Publicado: (2023)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020)

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
por: Eide, Turid, et al.
Publicado: (2013)

Pioneer Factors FOXA1 and FOXA2 Assist Selective Glucocorticoid Receptor Signaling in Human Endometrial Cells
por: Whirledge, Shannon, et al.
Publicado: (2017)

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
por: Robinson, Jessica L.L., et al.
Publicado: (2013)

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021)

Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
por: An, Jian, et al.
Publicado: (2014)

Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
por: Domanskyi, Andrii, et al.
Publicado: (2014)

Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
por: Gao, Shuai, et al.
Publicado: (2020)

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
por: Guiu, Séverine, et al.
Publicado: (2018)

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
por: Mangia, Anita, et al.
Publicado: (2019)

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
por: Dagher, Elie, et al.
Publicado: (2019)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)

FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes
por: Adams, Elizabeth J., et al.
Publicado: (2019)

FOXA1 defines cancer cell specificity
por: Zhang, Gaihua, et al.
Publicado: (2016)

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
por: Zhou, Stanley, et al.
Publicado: (2020)

FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021)

THU479 FOXA1 Loss Remodels The Tumor Immune Microenvironment In Late-stage Prostate Cancer
por: Brea, Lourdes T, et al.
Publicado: (2023)

FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
por: Robinson, Jessica L. L., et al.
Publicado: (2012)

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
por: Celada, Sherly I., et al.
Publicado: (2023)

The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling
por: Correa, Ricardo G., et al.
Publicado: (2014)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

FOXA1 mutations in hormone-dependent cancers
por: Robinson, Jessica L. L., et al.
Publicado: (2013)

FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell
por: Tao, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okq1i8n8p9s6mbi16o2g95rst0